Education
About Us
Working with TipRanks
Follow Us
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
ZBIO Analyst Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ZBIO Stock 12 Month Forecast
Average Price Target
$43.50
▲(87.26% Upside)
| Highest Price Target$55.00 | Average Price Target$43.50 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Evercore ISI
$55
Buy
136.76%
Upside
Reiterated
03/17/26
Wedbush
$45
Buy
93.72%
Upside
Reiterated
03/17/26
H.C. Wainwright
$44
Buy
89.41%
Upside
Reiterated
03/17/26
Citi
$43→$41
Buy
76.50%
Upside
Assigned
03/17/26
Guggenheim
$45→$55
Buy
136.76%
Upside
Reiterated
03/16/26
Morgan Stanley
$19→$21
Hold
-9.60%
Downside
Reiterated
03/16/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
$55
Buy
136.76%
Upside
Reiterated
03/17/26
Wedbush
$45
Buy
93.72%
Upside
Reiterated
03/17/26
H.C. Wainwright
$44
Buy
89.41%
Upside
Reiterated
03/17/26
Citi
$43→$41
Buy
76.50%
Upside
Assigned
03/17/26
Guggenheim
$45→$55
Buy
136.76%
Upside
Reiterated
03/16/26
Morgan Stanley
$19→$21
Hold
-9.60%
Downside
Reiterated
03/16/26
Best Analysts Covering Zenas BioPharma, Inc.
3 Months
xxx
Success Rate
5/9 ratings generated profit
Average Return
+17.76%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +17.76% per trade.
1 Year
Success Rate
6/9 ratings generated profit
Average Return
+74.26%
reiterated a buy rating last month
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +74.26% per trade.
2 Years
xxx
Success Rate
6/9 ratings generated profit
Average Return
+57.36%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +57.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ZBIO Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
4
2
2
6
9
Buy
7
11
15
9
5
Hold
30
41
48
50
38
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
54
65
65
52
Each month's total comprises the sum of three months' worth of ratings.
ZBIO Financial Forecast
ZBIO Stock Forecast FAQ
What is ZBIO’s average 12-month price target, according to analysts?
Based on analyst ratings, Zenas BioPharma, Inc.’s 12-month average price target is 43.50.
What is ZBIO’s upside potential, based on the analysts’ average price target?
Zenas BioPharma, Inc. has 87.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ZBIO a Buy, Sell or Hold?
Zenas BioPharma, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
What is Zenas BioPharma, Inc.’s price target?
The average price target for Zenas BioPharma, Inc. is 43.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $55.00 ,the lowest forecast is $21.00. The average price target represents 87.26% Increase from the current price of $23.23.
The highest analyst price target is $55.00 ,the lowest forecast is $21.00. The average price target represents 87.26% Increase from the current price of $23.23.
What do analysts say about Zenas BioPharma, Inc.?
Zenas BioPharma, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of ZBIO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.